Home  »  Companies   »  Why Assembly Biosciences Inc. (ASMB) Stock Could S...

Why Assembly Biosciences Inc. (ASMB) Stock Could See Much Higher Prices Ahead

Assembly Biosciences Inc. (NASDAQ: ASMB) is -29.09% lower on its value in year-to-date trading and has touched a low of $4.01 and a high of $27.84 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ASMB stock was last observed hovering at around $4.38 in the last trading session, with the day’s loss setting it -0.09% off its average median price target of $13.00 for the next 12 months. It is also 71.4% off the consensus price target high of $15.00 offered by 6 analysts, but current levels are 28.5% higher than the price target low of $6.00 for the same period.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Currently trading at $4.29, the stock is -1.22% and -9.53% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.97 million and changing -2.05% at the moment leaves the stock -61.01% off its SMA200. ASMB registered -76.71% loss for a year compared to 6-month loss of -71.03%. The firm has a 50-day simple moving average (SMA 50) of $4.5082 and a 200-day simple moving average (SMA200) of $6.7962.

The stock witnessed a -4.67% gain in the last 1 month and extending the period to 3 months gives it a -22.98%, and is -1.83% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.03% over the week and 4.09% over the month.

Assembly Biosciences Inc. (ASMB) has around 139 employees, a market worth around $174.69M and $79.10M in sales. Profit margin for the company is -78.60%. Distance from 52-week low is 6.98% and -84.59% from its 52-week high.

Assembly Biosciences Inc. (ASMB) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Assembly Biosciences Inc. (ASMB) is a “Overweight”. 6 analysts offering their recommendations for the stock have an average rating of 2.00, where 2 rate it as a Hold and 1 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Assembly Biosciences Inc. is expected to release its quarterly report on 08/11/2021 and quarterly earnings per share for the current quarter are estimated at -$0.79 with sales reaching $2.51M over the same period.The EPS is expected to grow by 52.80% this year, but quarterly earnings will post -88.80% year-over-year.

Assembly Biosciences Inc. (ASMB) Top Institutional Holders

166 institutions hold shares in Assembly Biosciences Inc. (ASMB), with 641.39k shares held by insiders accounting for 1.68% while institutional investors hold 69.85% of the company’s shares. The shares outstanding are 35.19M, and float is at 31.49M with Short Float at 12.80%. Institutions hold 68.68% of the Float.

The top institutional shareholder in the company is Blackrock Inc. with over 2.78 million shares valued at $16.84 million. The investor’s holdings represent 6.95% of the ASMB Shares outstanding. As of Dec 30, 2020, the second largest holder is Armistice Capital, LLC with 2.62 million shares valued at $15.88 million to account for 6.55% of the shares outstanding. The other top investors are Satter Management Company, LP which holds 2.23 million shares representing 5.56% and valued at over $13.48 million, while Consonance Capital Management LP holds 4.92% of the shares totaling 1.97 million with a market value of $11.92 million.

Assembly Biosciences Inc. (ASMB) Insider Activity

A total of 5 insider transactions have happened at Assembly Biosciences Inc. (ASMB) in the last six months, with sales accounting for 2 and purchases happening 3 times. The most recent transaction is an insider sale by Papkoff Jacqueline Sybil, the company’s SVP-CSO Microbiome. SEC filings show that Papkoff Jacqueline Sybil sold 1,297 shares of the company’s common stock on Dec 14 at a price of $6.15 per share for a total of $7983.0. Following the sale, the insider now owns 37364.0 shares.

Assembly Biosciences Inc. disclosed in a document filed with the SEC on Nov 09 that Stamm Luisa M (Chief Medical Officer) sold a total of 4,397 shares of the company’s common stock. The trade occurred on Nov 09 and was made at $5.10 per share for $22404.0. Following the transaction, the insider now directly holds 7603.0 shares of the ASMB stock.

Still, SEC filings show that on Aug 07, McHutchison John G (CEO and President) disposed off 12,151 shares at an average price of $21.80 for $0.26 million. The insider now directly holds 137,849 shares of Assembly Biosciences Inc. (ASMB).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Assembly Biosciences Inc. (ASMB): Who are the competitors?

The company’s main competitors (and peers) include Ironwood Pharmaceuticals Inc. (IRWD) that is trading 10.07% up over the past 12 months. Short interest in the company’s stock has fallen -9.81% from the last report on Apr 14, 2021 to stand at a total of 4.03 million short shares sold with a short interest ratio of 4.69.

Related Posts




Download Free eBook For

100% free. stop anytime no spam